NATF Official Statement and Action Plan on Follow-On Biosimiliars: Update and Open Discussion

Saturday, July 11, 2009
12:00-5:00 PM, Boston Massachusetts

This is an important meeting to discuss 3 bills introduced to the US Congress and Senate related to Follow-on Biologics. The agenda includes:

• Update on Heparin Contaminants and Quality Issues Surrounding Unfractionated Heparin
• Current Issues and Statements Surrounding Biosimilars and Follow-on Biologics
• Summary of United States Legislation and Proposed Bills
  • Waxman Bill: H.R. 1427
  • Eschoo Bill: H.R. 1548
  • Schumer Bill: S. 726
• NATF Official Statement on Follow-On Biosimilars
• NATF Action Plan
• Responses from patients, the general public, the International Society on Thrombosis and Haemostatis, public policy makers, and economic experts

More information related to the issue of Biosimilars and Follow-on Biolgoics can be found on NATF's website at natfonline.org/fob_update.php.